Articles Tagged With:
-
Full July 2004 Issue in PDF
-
Pharmacology Watch: Britain to Allow Over-the-Counter Sales of Zocor
The British government will soon allow over-the-counter sales of Mercks simvastatin (Zocor), marking the first time any country has allowed the OTC sale of a statin. -
Clinical Briefs in Primary Care Supplement
-
Pre-Discharge Beta Blockers for Heart Failure
The pre-discharge initiation of beta blocker therapy for decompensated heart failure patients increased the number of patients on beta blockers at 60 days without an increase in length of stay or adverse effects. -
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Data showed a strong trend toward benefit with ICD therapy in patients with nonischemic cardiomyopathy. -
Much More About CRP!
CPR values as a continuous variable have independent predictive value for subsequent coronary events in apparently healthy women. -
COX-2 Inhibitor Controversy
Current rofecoxib use was associated with a higher risk of acute myocardial infarction or admission for heart failure compared to celecoxib. -
Cardiac-Resynchronization Therapy in Advanced Chronic Heart Failure
In selected patients, cardiac resynchronization therapy with a pacemaker or pacemaker-defibrillator improves their clinical course and the addition of a defibrillator with cardiac resynchronization therapy alone further reduces mortality. -
Full June 28, 2004, Issue in PDF
-
Full June 2004 Issue in PDF